文献速递慢性肾脏病

SLC7A11/谷胱甘肽/谷胱甘肽过氧化物酶4轴的抑制驱动血管平滑肌细胞铁死亡促进血管钙化

Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification.
PubMed 文献 · Kidney Int · 2022-09-03

研究探讨铁死亡在慢性肾脏病(CKD)血管钙化中的作用。高钙高磷诱导大鼠血管平滑肌细胞(VSMC)铁死亡,铁死亡抑制剂ferrostatin-1剂量依赖性减少矿物质沉积并抑制成骨分化;ferrostatin-1或去铁胺减轻CKD大鼠主动脉钙化。机制上高钙高磷下调SLC7A11、GSH含量和GPX4表达及活性,抑制该轴触发VSMC铁死亡促进血管钙化。

要点

  • 高钙高磷诱导大鼠VSMC铁死亡,ferrostatin-1剂量依赖性减少钙化。
  • ferrostatin-1或去铁胺减轻CKD大鼠主动脉钙化。
  • 抑制SLC7A11/GSH/GPX4轴触发VSMC铁死亡促进血管钙化。

核心结论

  • 抑制SLC7A11/GSH/GPX4轴触发VSMC铁死亡,在CKD条件下促进血管钙化,提供新的靶向策略。

研究设计与样本

  • 体外大鼠VSMC实验、离体大鼠和人动脉环实验、体内维生素D3过载小鼠和CKD大鼠模型及机制分析。

主要发现

  • 高钙高磷浓度在体外诱导大鼠VSMC铁死亡。
  • ferrostatin-1剂量依赖性减少促成骨条件下大鼠VSMC的矿物质沉积(茜素红染色和钙含量定量),并抑制成骨分化。
  • ferrostatin-1显著减轻离体大鼠和人动脉环钙化及体内维生素D3过载小鼠主动脉钙化。
  • ferrostatin-1或去铁胺减轻CKD大鼠主动脉钙化。
  • 高钙高磷下调VSMC中SLC7A11表达和GSH含量,下调GPX4表达并降低谷胱甘肽过氧化物酶活性。

临床怎么用

  • 原文结论提出靶向SLC7A11/GSH/GPX4轴是血管钙化的新策略,未给出具体临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vascular calcification is a common pathologic condition in patients with chronic kidney disease (CKD). Cell death such as apoptosis plays a critical role in vascular calcification. Ferroptosis is a type of iron-catalyzed and regulated cell death resulting from excessive iron-dependent reactive oxygen species and lipid peroxidation. However, it is unclear whether ferroptosis of vascular smooth muscle cells (VSMCs) regulates vascular calcification in CKD. Our results showed that high calcium and phosphate concentrations induced ferroptosis in rat VSMCs in vitro. Inhibition of ferroptosis by ferrostatin-1 dose-dependently reduced mineral deposition in rat VSMCs under pro-osteogenic conditions, as indicated by alizarin red staining and quantification of calcium content. In addition, gene expression analysis revealed that ferrostatin-1 inhibited osteogenic differentiation of rat VSMCs. Similarly, ferrostatin-1 remarkably attenuated calcification of rat and human arterial rings ex vivo and aortic calcification in vitamin D3-overloaded mice in vivo. Moreover, inhibition of ferroptosis by either ferrostatin-1 or deferoxamine attenuated aortic calcification in rats with CKD. Mechanistically, high calcium and phosphate downregulated expression of SLC7A11 (a cystine-glutamate antiporter), and reduced glutathione (GSH) content in VSMCs. Additionally, GSH depletion induced by erastin (a small molecule initiating ferroptotic cell death) significantly promoted calcification of VSMCs under pro-osteogenic conditions, whereas GSH supplement by N-acetylcysteine reduced calcification of VSMCs. Consistently, knockdown of SLC7A11 by siRNA markedly promoted VSMC calcification. Furthermore, high calcium and phosphate downregulated glutathione peroxidase 4 (GPX4) expression, and reduced glutathione peroxidase activity. Inhibition of GPX4 by RSL3 promoted VSMC calcification. Thus, repression of the SLC7A11/GSH/GPX4 axis triggers ferroptosis of VSMCs to promote vascular calcification under CKD conditions, providing a novel targeting strategy for vascular calcification.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Ye Y, Chen A, Li L, et al. Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification. Kidney Int. 2022. PMID: 36063875. doi:10.1016/j.kint.2022.07.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。